Journal of Lipid Research, Vol 38, 1571-1582, Copyright © 1997 by Lipid Research, Inc.

ARTICLES

Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells

N Brossard, M Croset, S Normand, J Pousin, J Lecerf, M Laville, JL Tayot and M Lagarde
INSERM U 352, Biochimie et Pharmacologie INSA-Lyon, Villeurbanne, France.

Docosahexaenoic acid (22:6) decreases blood platelet function and is highly concentrated in the brain where its depletion leads to functional impairments. Because the platelets and blood brain barrier capillary endothelium cannot hydrolyze the complex lipids for fatty acid (FA) uptake, nonesterified FA (NEFA) bound to albumin are assumed to be the delivery route of FA to these cells. The supply of 13C- labeled 22:6 to blood cells by plasma albumin was studied in humans after a single ingestion of this FA esterified in a triglyceride (TG). The 22:6 13C/12C ratio, measured by gas chromatography combustion- isotope ratio mass spectrometry was measured in lipid classes from albumin, platelets, leukocytes, and erythrocytes (taken as a tentative index of the brain uptake). Nonesterified [13C]22:6 bound to albumin was rapidly produced after ingestion, as a result of the hydrolysis of very low density lipoprotein (VLDL) plus chylomicron TG. We found that albumin carried another source of 22:6, lyso-phosphatidylcholines (lyso- PC), in which [13C]22:6 accumulated while the nonesterified [13C]22:6 reached its minimal plasma concentrations. Computation of the relative contribution of NEFA and lyso-PC for the [13C]22:6 delivery to platelets and erythrocytes showed that the [13C]22:6 supply to platelets occurred uniquely through NEFA, whereas this pool was weakly involved in the delivery to erythrocytes. In contrast, lyso-PC was uniquely concerned with the 22:6 delivery to erythrocytes and represented the major part of this supply. We conclude that plasma albumin carries 22:6 in two lipid forms that are involved differently in the delivery of this FA to target cells.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. S Harris The omega-3 index as a risk factor for coronary heart disease Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1997S - 2002S. [Abstract] [Full Text] [PDF]

				N. Vaisman, N. Kaysar, Y. Zaruk-Adasha, D. Pelled, G. Brichon, G. Zwingelstein, and J. Bodennec Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1170 - 1180. [Abstract] [Full Text] [PDF]

				W. S Harris, J. V Pottala, S. A Sands, and P. G Jones Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1621 - 1625. [Abstract] [Full Text] [PDF]

				C. M. Skeaff, L. Hodson, and J. E. McKenzie Dietary-Induced Changes in Fatty Acid Composition of Human Plasma, Platelet, and Erythrocyte Lipids Follow a Similar Time Course J. Nutr., March 1, 2006; 136(3): 565 - 569. [Abstract] [Full Text] [PDF]

				L. Zhou and A. Nilsson Sources of eicosanoid precursor fatty acid pools in tissues J. Lipid Res., October 1, 2001; 42(10): 1521 - 1542. [Abstract] [Full Text] [PDF]

				D. Lemaitre-Delaunay, C. Pachiaudi, M. Laville, J. Pousin, M. Armstrong, and M. Lagarde Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [13C]DHA in phosphatidylcholine J. Lipid Res., October 1, 1999; 40(10): 1867 - 1874. [Abstract] [Full Text]

				N. Bernoud, L. Fenart, C. Bénistant, J. F. Pageaux, M. P. Dehouck, P. Molière, M. Lagarde, R. Cecchelli, and J. Lecerf Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood–brain barrier endothelial cells in vitro J. Lipid Res., September 1, 1998; 39(9): 1816 - 1824. [Abstract] [Full Text]